InvestorsHub Logo
Followers 0
Posts 117
Boards Moderated 0
Alias Born 05/27/2018

Re: None

Wednesday, 05/01/2019 10:05:06 AM

Wednesday, May 01, 2019 10:05:06 AM

Post# of 9827
I’m trying to figure out the difference in this PR and the announcement that Oncbiomune posted on their website on February 28th.
It isn’t really new news unless the “letter” from Cato made it official.

http://oncbiomune.com/2019/02/28/oncbiomune-announces-consulting-agreement-with-cato-research-llc-for-developing-pgt-a-protein-drug-complex-targeting-cd71-for-refractory-cancers/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent THER News